bonusgamedownload| Jianhui Information's acquisition completed, counterparties announced that nearly 13.51 million yuan had purchased assets of Meituan's drug-buying smart retail project

It took about 4 months to announce that the acquisition of the "Smart Retail Project" business had been completed on the evening of May 20, with a transaction value of 1350 yuan.BonusgamedownloadAt the same time, it was announced for the first time.BonusgamedownloadThe counterparty to the transaction is Beijing Sankuai online Technology Co., Ltd., and the target of the transaction is Meituan's drug-buying wisdom retail project.

On February 9, Jianwei Information disclosed for the first time that it had signed a strategic cooperation agreement for "Smart drugstore", but the specific counterparty of the transaction was not disclosed. Health Information promises to give priority to the production of digital intelligence equipment that the project needs to put in, to provide 7x24 hourly operation and maintenance guarantee, and to actively develop new products suitable for the project, and a company promises to provide technical support and project operation support. The term of cooperation is three years, that is, from February 9, 2024 to February 8, 2027.

On April 24, Jianwei Information once again disclosed the progress of the transaction, showing that the two sides signed an agreement on the acquisition of the "Smart Retail Project" business, in which the existing smart drugstore business on the side of a company was evaluated and approved by both parties. It will be purchased by Jianwei Information and transferred into the body of Jianwei Information for operation. Specific transaction assets include smart retail project assets currently operated by the counterparty, including 166 hardware equipment, 8 software system licenses, more than 100 business contracts, 70 technical documents, etc.

According to the evaluation, the estimated value of the underlying asset is 1376.BonusgamedownloadThe estimated value is 711100 yuan higher than the book value, with a value-added rate of 5.45%. On this basis, the two parties to the transaction negotiated to determine the transaction price of 13.506 million yuan.

For the significance of this transaction, the introduction of Jianyu Information is mainly aimed at promoting the in-depth development of the "Smart Pharmacy Project". Jianwei Information will rely on the strong customer base advantages of the counterparty, profound retail experience and the empowerment of system solutions. rapidly expand market share and lay a solid foundation for the expansion of the new retail market. After the completion of this transaction, it will help to enhance the profitability of the company. In addition, the cash transaction capital pressure is relatively small, will not affect the normal production and operation of listed companies.

On the evening of May 20, the update progress of Jianqi information announced that the transaction had completed the asset delivery process, and for the first time it was disclosed that the counterparty to the transaction was Beijing Sankuai online Technology Co., Ltd., and the underlying asset is the smart retail project currently operated by Meituan.

At the same time, health information indicates that the specific impact of the signing of this agreement on the company's annual and future fiscal years is uncertain, and the impact on the company's future operating performance depends on the promotion and implementation of specific cooperation projects.

However, just as Jianwei Information began to buy Meituan's drug-buying smart retail project, the listed company's IPO fund-raising project announced the postponement.

In March this year, the health information announcement IPO investment project pharmacy automation upgrade research and development, automation equipment delivery project is expected to be completed from April 2024 to March 2025. By the end of February, the progress of the above two projects was 31% and 12.09% respectively, while other fund-raising projects had been completed.

As for the reasons for the delay, Jianwei Information said that the delay in the R & D project of pharmacy automation upgrading is mainly due to the fact that the domestic automation R & D pharmacy automation field is still in the initial stage of growth, coupled with the slowdown in global economic growth, these factors have led to a slowdown in domestic demand for R & D and upgrading of automated pharmacies. In the early stage, after carefully evaluating its own production capacity and the actual demand of the domestic market, the company appropriately controlled the progress of capacity construction.

In addition, the delay of the automation equipment delivery project is mainly due to the strong demand of medical institutions for automated pharmacies, however, the actual acceptance and purchase volume may be affected by budget constraints, difficulty in the transformation of existing facilities and adaptability to new technologies. At present, there is a certain time period for the financial recovery of medical institutions, which leads to the slow process of putting and upgrading automatic pharmacy equipment.

Jianwei information pointed out that although the implementation progress of the aforementioned fund-raising project is temporarily affected by internal and external factors, the company actively adjusts its development strategy and continues to promote its business in overseas markets.BonusgamedownloadIt has established a deep and specific strategic partnership with Internet enterprises in the new retail industry. This will provide strong support for the pharmacy automation upgrade R & D project and automation equipment delivery project in the future. In the future, the company will speed up the implementation of the above-mentioned project to ensure high-quality completion of the project.

Due to the periodic market fluctuations brought about by the industry policy reform and the shortage of local government funds, the business demand of listed companies has declined. Last year, the net profit attributable to Jianyu information was about 60 million yuan, down nearly 50% from the same period last year; in the first quarter of this year, the company achieved a net profit of 5.242 million yuan, down again from the same period last year.

Tags:

Prev: neon54casinonodepositbonus| International Medicine: The company plans to repurchase no more than 16.3755 million shares of the company
Next: freespinvideopoker| Credit test standard (300938.SZ): 2023 equity distribution 10 transfers 4.5 transfers 3.3 yuan equity registration date May 24